News
One-year results from the Pavilion study showed patients who received Susvimo (ranibizumab) refilled every nine months ...
Most clinical trials test new treatments only after cancer has relapsed and grown large enough to be detected on scans. The ...
1d
Vietnam Investment Review on MSNNew report charts path for Vietnam’s clinical trial growthPharma Group released the ‘Roadmap to the Future of Clinical Trials in Vietnam’ report on May 20 in Ho Chi Minh City.
Researchers demonstrated unprecedented rates of recovery for spinal cord injuries. Individuals with incomplete spinal cord injury safely received a combination of stimulation of a nerve in the neck ...
In this video interview, Michel van Harten, MD, CEO, myTomorrows, highlights how artificial intelligence can be used to address logistical barriers such as access and treatment cost.
The safety findings were reported to be consistent with the known profiles of ficerafusp alfa and pembrolizumab, and post-treatment data from tumor biopsies indicated a promising downregulation of ...
Media ReleaseCOPENHAGEN, Denmark; May 22, 2025 First presentation of results from Phase 1/2 clinical trial of investigational rinatabart sesutecan (Rina-S®) in patients with recurrent/advanced endomet ...
The university’s Center for Vaccine Development is recruiting people for a study into pre-existing flu immunity in healthy ...
Having already worked with clinical trial sites in more than 14 states, CTAC will now take its work nationwide, the ...
2d
Clinical Trials Arena on MSNUK clinical trial sector progress ‘remarkable’, says former health ministerThe progress the UK has made as a global contributor to clinical trials is “remarkable”, says Lord James O’Shaughnessy, ...
On Clinical Trials Day, speakers emphasized how lack of representation impacts medical care for Black women and strategies for participation.
The reductions in NIH funding and staff are happening at a time when colorectal cancer cases have been rising among younger ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results